Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer
Salahuddin S, Cohen O, Wu M, Irizarry J, Vega T, Gan G, Deng Y, Isaeva N, Prasad M, Schalper K, Mehra S, Yarbrough W, Emu B. Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. Clinical Infectious Diseases 2022, 76: 1449-1458. PMID: 36520995, PMCID: PMC10319962, DOI: 10.1093/cid/ciac924.Peer-Reviewed Original ResearchConceptsOverall survivalIndependent predictorsHNSCC patientsWorse prognosisOropharyngeal tumorsCox proportional hazards regression modelMultivariate analysisHPV-positive oropharyngeal tumorsNeck squamous cell cancerProportional hazards regression modelsLower median overall survivalAcademic hospital centerNon-HIV populationMedian overall survivalPredictors of survivalSquamous cell cancerHuman immunodeficiency virusPoor clinical outcomeExpression of CD4Poor overall survivalHazards regression modelsRace/ethnicityCD8 infiltrationHazard ratioClinicopathologic characteristicsNSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma
Jain D, Nambirajan A, Chen G, Geisinger K, Hiroshima K, Layfield L, Minami Y, Moreira A, Motoi N, Papotti M, Rekhtman N, Russell P, Prince S, Schmitt F, Yatabe Y, Eppenberger-Castori S, Bubendorf L, Beasley M, Berezowska S, Borczuk A, Brambilla E, Chou T, Chung J, Cooper W, Dacic S, Chan Y, Hirsch F, Hwang D, Joubert P, Kerr K, Lantuejoul S, Lin D, Lopez-Rios F, Matsubara D, Mino-Kenudson M, Nicholson A, Poleri C, Roden A, Schalper K, Sholl L, Thunnissen E, Travis W, Tsao M, Wistuba I, Chen G. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma. Journal Of Thoracic Oncology 2022, 17: 793-805. PMID: 35331963, DOI: 10.1016/j.jtho.2022.02.013.Peer-Reviewed Original Research